TITLE

Maternal serum screening

PUB. DATE
April 1999
SOURCE
CMAJ: Canadian Medical Association Journal;4/20/99, Vol. 160 Issue 8, p1125
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
22954948

 

Related Articles

  • Noninvasive screening for prenatal genetic diagnosis. Simpson, J.L. // Bulletin of the World Health Organization;1995, Vol. 73 Issue 6, p799 

    Examines three different approaches to noninvasive prenatal genetic diagnosis without risk. Applicability in mass screening programs; Maternal serum screening; Possible use of ultrasonography.

  • Maternal serum screening for Down's syndrome in early pregnancy. Wald, Nicholas J.; Cuckle, Howard S.; Densem, James W.; Nanchahal, Kiran; Royston, Patrick; Chard, Tim; Haddow, James E.; Knight, George J.; Palomaki, Glenn E.; Canick, Jacob A. // BMJ: British Medical Journal (International Edition);10/8/88, Vol. 297 Issue 6653, p883 

    Examines the maternal serum screening for Down's syndrome in early pregnancy in Great Britain. Description of the syndrome; Measurement of human chronic gonadotropin concentrations; Effectiveness of the screening method.

  • Prenatal screening for trisomy 18 with free beta human chorionic gonadotrophin as a marker. Spencer, K.; Mallard, A.S.; Coombes, E.J.; Macri, J.N. // BMJ: British Medical Journal (International Edition);12/4/93, Vol. 307 Issue 6917, p1455 

    Examines the relationship between maternal serum alpha fetoprotein and free beta human chorionic gonadotrophin concentrations during pregnancies. Development of prenatal biochemical screening; Analysis on stored maternal serum from similar pregnancies; Use of maternal age and concentrations of...

  • Screening for Down's syndrome using serum alpha fetoprotein: a retrospective study indicating caution. Spencer, K.; Carpenter, P. // British Medical Journal (Clinical Research Edition);6/29/1985, Vol. 290 Issue 6486, p1940 

    Investigates the efficacy of medical screening of Down's syndrome using serum alpha fetoprotein in Great Britain. Comparison of various screening strategies; Identification of pregnancies affected by the disease; Measurement of maternal serum alpha fetoproteins.

  • Screening for Down's syndrome. Vyas, Sanjay // BMJ: British Medical Journal (International Edition);9/24/94, Vol. 309 Issue 6957, p753 

    Focuses on Down's syndrome and mental retardation. Anomalies accompanying the syndrome; Incidence of the syndrome during birth; Screening of maternal serum in assessing risk of the syndrome in pregnancy.

  • maternal serum screen.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1413 

    A definition of the term "maternal serum screen," which refers to a blood test taken to determine the presence of congenital disease in the fetus of a pregnant woman, is presented.

  • ACOG Issues Educational Bulletin on Maternal Serum Screening.  // American Family Physician;3/1/1997, Vol. 55 Issue 4, p1454 

    Presents an educational bulletin on maternal serum screening, from the American College of Obstetrician and Gynecologists. Type of information included in the bulletin; Detailed analysis of the bulletin; Contact information.

  • Family Practice International. Walling, Anne D. // American Family Physician;6/15/2000, Vol. 61 Issue 12, p3733 

    Summarizes the results of several studies on family medicine. Transmission of coxsackie B virus infection; Update on schizophrenia; Attitudes of women toward maternal serum screening.

  • Maternal serum alphafetoprotein in pregnancy and the prevention of birth defect. Harris, Rodney // British Medical Journal;5/17/1980, Vol. 280 Issue 6225, p1199 

    Focuses on the introduction of maternal serum alphafetoprotein screening programs in pregnancy. Prevention of birth defects; Impact of growth of prenatal diagnosis and selective abortion on couples; Description of alphafetoprotein.

  • Screening for Down's syndrome in the North East Thames Region. Murday, Victoria; Slack, Joan // British Medical Journal (Clinical Research Edition);11/9/1985, Vol. 291 Issue 6505, p1315 

    Examines the screening program for Down's syndrome in the North East Thames Regional Health Authority in Europe. Use of maternal serum alpha fetoprotein for screening; Risk associated with the program; Reduction of the amniocentesis.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics